ABSTRACT We obtained 12 groups of mice with widely different neurological responses to levodopa by selecting them from different strains and submitting some of them to pretreatments. We scored the symptoms evoked by a standardized dose of levodopa in one subgroup from each group. We tested another subgroup for activation of an adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] by a standardized dose of dopamine added to homogenates of the caudate nuclei of the brains of these mice. Both sets of tests were performed randomly. When the accruing two sets of data were plotted against each other there emerged a straight line which fitted the data with a coefficient of correlation of 0.97 (P < 0.0001). The dopamine-dependent activity of the adenylate cyclase of the brain was thus shown to be a determinant of the neurological responses of intact animals to a dopaminergic drug.
Greengard and his colleagues discovered a dopamnine-activated adenylate cyclase in homogenates of caudate nuclei (1-3) which appears to be the site of interaction between dopamine and the receptors on the membranes of postsynaptic dopaminergic neurons. The enzyme synthesizes a second messenger, adenosine 3':5'-cyclic monophosphate (cyclic AMP), governing the neuron's response to dopamine.
-This enzyme seems to play a behavioral role in animals and man since neuroactive drugs tested against the adenylate cyclase have imitated drug effects seen in animals or man. The dopamine-dependent activity, for example, was selectively inhibited by antipsychosis drugs that block the mental effects of dopamine (4) (5) (6) (7) (8) . These drugs, however, can induce pharmacological parkinsonism. Dopaminergic drugs in low concentrations potentiated selectively the enzyme's dopaminedependent activity but higher concentrations caused inhibition (2, 9) . Furthermore, mutually antagonistic drugs, the cholinergic and anticholinergic ones, both-inhibited this enzyme (9) . The sum of this evidence was only suggestive but did not prove a behavioral function of this enzymatic activity (9) . It was useful, therefore, to seek quantitative correlations between (i) selected neurological or behavioral scores in intact animals and (ii) the dopamine-dependent activity of the cyclase in homogenates of brains from corresponding animals. Such a correlation would strengthen the assumption of a behavioral role without precluding a search for further functions (9) .
We had found earlier that the intensity of neurological responses evoked by standard single doses of levodopa in mice was sex-dependent (10) and was influenced by some genetic factors (11) and some pharmacological pretreatments (12, 13) . One could therefore select appropriate groups so that the reactions of the mice in each group to single injections of levodopa would differ from those of the other groups (11) (12) (13) . One thereafter, in corresponding mice, the degree by which standard concentrations of dopamine activate the adenylate cyclases in homogenates of the caudate. A significant correlation between the two sets of data would argue that the dopaminedependent activity of the cyclase is a determinant of the neurological responses of animals to a dopaminergic drug.
MATERIALS AND METHODS Animals. These were 6-to 8-week-old mice, divided into the 12 groups described below. These groups were subdivided into subgroups of at least 20 mice for study of the neurological scores after intraperitoneal injection of levodopa (0.4 mg/g of body weight) and of at least 12 mice for determinations of the adenylate cyclase activities. They weighed 22-27 g at the outset and were maintained on water ad libitum and Purina Chow with or without the additives indicated below. They were kept on a 12-hr light-and-darkness cycle and all tests were conducted in midday.
The following groups of mice were tested: (a) male Swiss albinos of the Hale-Stoner strain (HS) pretreated by intubation with chlorambucil (Leukeran, p-di-2-chlorethylaminophen- (12) Mixing and incubation were carried out in a 30°water bath. The reaction was stopped 2.5 min later by immersion in a boiling-water bath for 2 min. The homogenates were centrifuged at 1500 X g for 5 min; the supernatant solutions were quick-frozen and were kept at -20°until analyzed for cyclic AMP by the method of Gilman (14) .
Calculations. The mean +SEM was computed for the neurological scores and for the basal activities of adenylate cyclase in each group. The mean of the basal activities was subtracted from the mean of the corresponding total activities to yield the net stimulated activity for each subgroup (pmol of cyclic AMP per both caudates). These means and their standard errors were plotted linearly against the means and standard errors of the corresponding scores. The coefficient of correlation of the data with the ensuing line, the P value, and the intercept were cal-culated by using a FORTRAN program with code word "REGN" in a CDC 6600 computer. RESULTS The scores produced by standardized intraperitoneal injections of levodopa in the subgroups that were pretreated with chlorambucil, estradiol, or estradiol plus ovariectomy (Fig. 1) were similar to those after injections of saline. Also, negligible reactions were induced by our standardized doses of levodopa in the otherwise untreated subgroup of female C3H/HeJ mice. The corresponding determinations of the net dopamine-dependent adenylate cyclase activity showed absence of measurable activation of the enzyme by dopgmine. The eight other groups showed different degrees of responsiveness to injected levodopa as indicated by the neurological scores. The in vitro tested adenylate cyclase activities showed different degrees of responsiveness to added standard doses of dopamine. The xintercept of the plot of these two sets of randomly obtained data, expressed as means, was 6.7, roughly similar to the value obtained from saline-injected mice. The coefficient of correlation for the data was 0.97 (P < 0.0001).
In contrast to the net dopamine-stirnulated adenylate cyclase activities, the basal activities remained essentially similar from strain to strain and from one pretreatment to the next. The female mice, however, showed a mean basal activity of 354 ± 12 pmol of cyclic AMP per 2.5 min, as opposed to 294 + 5 for the males (P < 0.0001). This sex-linked difference of the basal activities was thus the only difference encountered or induced in the basal activities of the adenylate cyclase. There was, therefore, no correlation between the basal activities and the behavioral parameters studied here, in sharp contrast to the dopamine-dependent activities.
DISCUSSION
Female mice showed less-pronounced neurological responses than did males to single intraperitoneal injections of levodopa. Earlier, females were found (10) to be much more tolerant than males of levodopa incorporated in their diets. These differences might be due to some long-term, indirect effects of estrogens for the following reasons: (i) removing the ovaries increased eventually the animals' responses to levodopa; (ii) chronic administration of an estrogen diminished these responses; and (iii) additions of 10 ,gM estradiol to the reaction mixture had no effects on the adenylate cyclase reaction or on its activation by dopamine (unpublished data). We have not encountered such a sex-linked difference in man, probably because our patients are postmenopausal.
Chlorambucil pretreatment diminished the responses of the mice to levodopa, as had some other chemotherapeutic agents discussed in an earlier publication (12) . In all these instances (12), the diminished neurological scores were associated with a lessening of the net dopamine-dependent activity of the caudates' adenylate cyclase.
In addition to these sex-or drug-linked differences in the intensity of the neurological reactions of mice to levodopa, we had demonstrated earlier some genetically determined differences-for example, in the manganese mouse mutant pallid (papa) versus its C57 BL/6J (PaPa) control (11) . Genetically determined differences were also found here. Now, however, they were correlated convincingly with dopamine-dependent activity of the adenylate cyclase, as were the nongenetic differences in neurological responses. This quantitative correlation argues that the dopamine-dependent activity of cerebral adenylate cyclases is a determinant of the neurological responses of animals to a dopamine agonist. This enzyme therefore plays a behavioral role, which is not necessarily its only function (9) . 
